- Home
- RVP vs DWTX Comparison
RVP vs DWTX Comparison
Compare RVP & DWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVP
- DWTX
- Stock Information
- Founded
- RVP 1994
- DWTX 2012
- Country
- RVP United States
- DWTX United States
- Employees
- RVP N/A
- DWTX N/A
- Industry
- RVP Medical/Dental Instruments
- DWTX
- Sector
- RVP Health Care
- DWTX
- Exchange
- RVP Nasdaq
- DWTX NYSE
- Market Cap
- RVP 23.0M
- DWTX 5.9M
- IPO Year
- RVP 2001
- DWTX N/A
- Fundamental
- Price
- RVP $0.75
- DWTX $7.73
- Analyst Decision
- RVP
- DWTX
- Analyst Count
- RVP 0
- DWTX 0
- Target Price
- RVP N/A
- DWTX N/A
- AVG Volume (30 Days)
- RVP 49.7K
- DWTX 3.0M
- Earning Date
- RVP 03-28-2025
- DWTX 03-25-2025
- Dividend Yield
- RVP N/A
- DWTX N/A
- EPS Growth
- RVP N/A
- DWTX N/A
- EPS
- RVP N/A
- DWTX N/A
- Revenue
- RVP $38,265,097.00
- DWTX N/A
- Revenue This Year
- RVP N/A
- DWTX N/A
- Revenue Next Year
- RVP N/A
- DWTX N/A
- P/E Ratio
- RVP N/A
- DWTX N/A
- Revenue Growth
- RVP N/A
- DWTX N/A
- 52 Week Low
- RVP $0.56
- DWTX $1.62
- 52 Week High
- RVP $1.23
- DWTX $29.28
- Technical
- Relative Strength Index (RSI)
- RVP 44.34
- DWTX N/A
- Support Level
- RVP $0.69
- DWTX N/A
- Resistance Level
- RVP $0.83
- DWTX N/A
- Average True Range (ATR)
- RVP 0.06
- DWTX 0.00
- MACD
- RVP -0.01
- DWTX 0.00
- Stochastic Oscillator
- RVP 34.37
- DWTX 0.00
About RVP Retractable Technologies Inc.
Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.
About DWTX DOGWOOD THERAPEUTICS INC
Dogwood Therapeutics Inc formerly Virios Therapeutics Inc is a development-stage biotechnology company. It is focused advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, such as fibromyalgia (FM) and Long-COVID (LC). Its product candidates includes IMC-1 and IMC-2, IMC-1, is intended to synergistically suppress herpesvirus activation and replication with a more specific activity against the Epstein-Barr virus (herpesvirus HHV-4, IMC-2 is a combination of valacyclovir and celecoxib.